<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137731</url>
  </required_header>
  <id_info>
    <org_study_id>2019-10138</org_study_id>
    <nct_id>NCT04137731</nct_id>
  </id_info>
  <brief_title>Use of Interferential Current (IFC) Therapy After Total Knee Arthroplasty</brief_title>
  <acronym>IFC</acronym>
  <official_title>The Effect of Short Term Patient Outcomes With the Use of Interferential Current Therapy After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ortho IFC LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interferential Current Therapy (IFC) is a form of electrical therapy that utilizes two&#xD;
      simultaneous low frequency electrical stimulation which when they cross interfere with one&#xD;
      another resulting in an interference or beat frequency. This beat frequency provides a&#xD;
      therapeutic area of relief by blocking painful stimuli at the area of interest. IFC is&#xD;
      different from the other electrical treatment modalities used because the cancellation effect&#xD;
      allows for establishment of the treatment area to be in the deeper tissues of the body,&#xD;
      whereas other electrical modalities can only be used to treat superficial body parts that lie&#xD;
      just under the skin.&#xD;
&#xD;
      The main objective of this proposed study is to assess the post-operative short term outcomes&#xD;
      of the patients who receive IFC treatment during their post-total knee arthroplasty (TKA)&#xD;
      surgery hospital stay. The implications of the study would be improved patient outcome which&#xD;
      could result in shorter hospital stay, reduced use of opioid medication, decreased need for&#xD;
      manipulation under anesthesia and reduced re-admission rate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2019</start_date>
  <completion_date type="Anticipated">November 3, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in post-operative pain medication usage</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Opioid use during the hospital stay after TKA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in post-operative pain medication usage</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Opioid use during the hospital stay after TKA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Range of Motion</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>The movement of knee joint, 0: fully straight - 135 : fully bent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Measure for Post Acute Care (AM-PAC) &quot;6-Clicks&quot; Basic Mobility Inpatient Short Form-Scores</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Patient Reported Outcome Tool used by physical therapist to asses patient's function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Pain Score (VAS)</measure>
    <time_frame>24 Hours after surgery</time_frame>
    <description>VAS asks a patient to mark a place on a scale that aligns with their level of pain smiley face =No pain - sad face =worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Pain Score</measure>
    <time_frame>48 Hours after surgery</time_frame>
    <description>VAS asks a patient to mark a place on a scale that aligns with their level of pain smiley face =No pain - sad face =worst pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <arm_group>
    <arm_group_label>IFC Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The IFC treatment will be used for 30 minutes, twice a day for two days after the total knee arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One set of device is programmed to be used as Placebo, the subject will feel the vibration but will not receive a therapeutic signal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interferential Current Therapy</intervention_name>
    <description>IFC treatment after Total Knee Arthroplasty</description>
    <arm_group_label>IFC Treatment</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Adult patients with knee osteoarthritis who have failed conservative&#xD;
        therapy and undergoing elected TKA.&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        i. &lt;18 years old ii. Any patient with pacemaker or any electrical stimulator device iii.&#xD;
        Patients without capacity to consent for the study iv. Patients not able to have local&#xD;
        nerve block or spinal anesthesia v. Patients with prior chronic opioid use vi. Patients who&#xD;
        are categorized to have 'Severe' fear and anxiety responses to pain, according to the Pain&#xD;
        catastrophizing scale (PCS) survey.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeynep Seref-Ferlengez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sun Jin Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sun Jin Kim, MD</last_name>
    <phone>(718) 920-2060</phone>
    <email>SUKIM@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zeynep Seref-Ferlengez, PhD</last_name>
    <phone>(929) 246-6352</phone>
    <email>sereffer@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Senior Operations Manager</last_name>
      <phone>347-577-4441</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 22, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

